Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. TUDCA attenuates the progression of HFD-induced NAFLD in mice by ameliorating gut inflammation, improving intestinal barrier function, decreasing intestinal fat transport and modulating intestinal microbiota composition.
Detox Learning Center
- 09 Aug 19
- 02 Aug 19
At Microbe Formulas, we live by this simple standard: Creating supplements that work is what we do. Restoring hope and health is who we are.
Phone: (866) 902-0977